Effects of ALK inhibitors (PF-02341066 and PF-06463922) with radiotherapy in EML4 – ALK fusion positive (H2228 and 185IG) and negative (A549) experimental lung cancer cell lines.
Saved in:
| Title: | Effects of ALK inhibitors (PF-02341066 and PF-06463922) with radiotherapy in EML4 – ALK fusion positive (H2228 and 185IG) and negative (A549) experimental lung cancer cell lines. |
|---|---|
| Authors: | Antoni, D.N.1,2 (AUTHOR), Burckel, H.2 (AUTHOR), Noel, G.1,2 (AUTHOR) |
| Source: | International Journal of Radiation Oncology, Biology, Physics. 2020 Supplement, Vol. 108 Issue 3, pe507-e508. 2p. |
| Subjects: | Anaplastic lymphoma kinase, Cell lines, Lung cancer, Cancer cells, Non-small-cell lung carcinoma |
| Database: | Engineering Source |
Be the first to leave a comment!
